California Life Sciences Association (CLSA) Announces Winners of 2017 Pantheon DiNA Awards
Trade association representing industry to recognize innovators for contributions to California’s life sciences sector at 14th Annual Pantheon Awards Program, Nov. 10 in San Francisco
SAN FRANCISCO & SAN DIEGO – Sept. 19, 2017 – California Life Sciences Association (CLSA), the statewide public policy and business leadership trade association representing California’s life sciences industry, today announced winners of the 2017 Pantheon DiNA Awards, a distinguished awards program honoring innovation and excellence within California’s life sciences sector.
The annual program, now in its 14th year, brings together more than 600 industry pioneers – including innovators, investors and educators – and recognizes the achievements and excellence of those dedicated to enhancing California’s life sciences community, a sector which employs nearly 300,000 Californians at over 3,000 life sciences companies. This year’s winners will be honored at the 2017 Pantheon DiNA Awards ceremony on Nov. 10 at the Marriott Marquis in San Francisco.
“California’s life sciences industry is delivering incredible value for the people of the Golden State and patients around the world. The recipients of the 2017 Pantheon Awards are some of California’s hardest working innovators and entrepreneurs who are producing the most advanced medicines, diagnostics and technologies to improve medical care,” said Sara Radcliffe, President and CEO, California Life Sciences Association (CLSA). “As the trade association representing this ecosystem, we look forward to bringing the sector together on Nov. 10 for the 2017 CLSA Pantheon DiNA Awards to celebrate the great leaders – both individuals and companies – that have made extraordinary contributions to the California life sciences community this year.”
2017 Pantheon DiNA Award Winners (Sorted by Award Category):
Life Sciences Leadership Awards:
Jay Flatley, Executive Chairman, Illumina
John Martin, Ph.D., Executive Chairman, Gilead Sciences
Outstanding Company Award: AbbVie
Outstanding Product Award, Therapeutic: Neurocrine Biosciences, INGREZZA
Outstanding Product, Medical Device/Diagnostic: Medtronic, MiniMed 670G System
Digital Health Innovation Award: Omada Health
Rising Star Award: Second Genome
Biotechnology Educator Award: Gladstone Institutes PUMAS Program
Ticketing, event and sponsorship information is available at www.clsapantheon.org. The event will commence on Nov. 10 with an opening reception at 5:30 p.m. PT, followed by a presentation and dinner at 7 p.m. PT. Members of the press may obtain complimentary registration by RSVP’ing to Will Zasadny, Director of Communications for California Life Sciences Association (CLSA) (Wzasadny@CALifeSciences.org or 619-961-8848). To learn more about CLSA and its offerings, please visit: www.califesciences.org.
More about CLSA’s Pantheon DiNA Awards:
Each year the California Life Sciences Association (CLSA), recognizes and honors excellence as it brings together California’s Life Sciences industry for one night at our Annual Pantheon DiNA Awards Ceremony. This evening serves as a celebration of the contributions and achievements of California’s leading life sciences innovators, a moment in time to pause and reflect on the industry’s legacy. You are cordially invited to join us on Friday, Nov. 10 at the Marriott Marquis in San Francisco as we celebrate and recognize the impact that California’s therapeutic, diagnostic, medical device, and industrial biotechnology companies are making around the globe. Ticketing, event and sponsorship information is available at www.clsapantheon.org.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
California Life Sciences Association (CLSA)
Will Zasadny | Director, Communications
Wzasadny@califesciences.org | 619-961-8848